Russell Investments Group Ltd. raised its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 13.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,533,665 shares of the real estate investment trust's stock after buying an additional 415,683 shares during the quarter. Russell Investments Group Ltd. owned about 0.51% of Healthpeak Properties worth $71,450,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of DOC. Nuveen LLC acquired a new stake in Healthpeak Properties during the first quarter valued at approximately $124,113,000. Resolution Capital Ltd acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $122,795,000. Long Pond Capital LP acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $86,885,000. Invesco Ltd. grew its holdings in Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after buying an additional 3,967,830 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Price Performance
Shares of DOC traded up $0.28 during trading hours on Friday, hitting $17.32. 6,201,670 shares of the company were exchanged, compared to its average volume of 6,054,607. The company has a market capitalization of $12.04 billion, a PE ratio of 72.17, a PEG ratio of 2.19 and a beta of 1.05. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The firm has a fifty day simple moving average of $17.64 and a 200-day simple moving average of $18.49. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. The company's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.45 earnings per share. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, September 19th will be issued a $0.1017 dividend. The ex-dividend date is Friday, September 19th. This represents a c) dividend on an annualized basis and a dividend yield of 7.0%. Healthpeak Properties's dividend payout ratio is presently 508.33%.
Insiders Place Their Bets
In other Healthpeak Properties news, Director Tommy G. Thompson bought 5,777 shares of Healthpeak Properties stock in a transaction dated Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the acquisition, the director directly owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker acquired 1,490 shares of the business's stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at $3,566,377.98. This represents a 0.71% increase in their position. The disclosure for this purchase can be found here. Insiders bought 14,560 shares of company stock valued at $249,898 in the last 90 days. Corporate insiders own 0.23% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on DOC shares. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Evercore ISI decreased their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price target for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wedbush decreased their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Wells Fargo & Company decreased their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $23.00.
View Our Latest Analysis on DOC
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report